Notice Type
Secondary Legislation
Notice Title

Provisional Consent to the Distribution of a New Medicine

Publication Date
26 Mar 2026

Tags

Medicines Act Provisional consent to the distribution of new medicines Health

Notice Number

2026-sl1628
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Audenz
Active Ingredient: Influenza virus haemagglutinin 7.5mcg
Dosage Form: Suspension for injection
New Zealand Sponsor: Seqirus (NZ) Limited
Manufacturer: Seqirus Inc., North Carolina, United States of America

Note: This consent is given subject to the following condition:

  • The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Pandemic Plan.
Note: This consent is valid for two years from the date of publication of this notice.


Dated this 23rd day of March 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).